Learning Objectives:

  1. Understand the impact of a comprehensive geriatric assessment on the evaluation of and outcomes of older stem cell transplant candidates
  2. Understand the rationale for measuring minimal residual disease (MRD) in multiple myeloma (MM)
  3. Learn how MRD can be used to guide decision making in MM and define operational cures
Session date: 
01/06/2020 - 12:00pm to 1:00pm CST
900 East 57th Street
KCBD Auditorium 1103
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Benjamin A. Derman, MD